Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 778

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples

Open access
Ianevski, Aleksandr, Giri, Anil K, Aittokallio, Tero·2022·Nucleic Acids Research

Abstract

SynergyFinder (https://synergyfinder.fimm.fi) is a free web-application for interactive analysis and visualization of multi-drug combination response data. Since its first release in 2017, SynergyFinder has become a popular tool for multi-dose combination data analytics, partly because the development of its functionality and graphical interface has been driven by a diverse user community, including both chemical biologists and computational scientists. Here, we describe the latest upgrade of this community-effort, SynergyFinder release 3.0, introducing a number of novel features that support interactive multi-sample analysis of combination synergy, a novel consensus synergy score that combines multiple synergy scoring models, and an improved outlier detection functionality that eliminates false positive results, along with many other post-analysis options such as weighting of synergy by drug concentrations and distinguishing between different modes of synergy (potency and efficacy). Based on user requests, several additional improvements were also implemented, including new data visualizations and export options for multi-drug combinations. With these improvements, SynergyFinder 3.0 supports robust identification of consistent combinatorial synergies for multi-drug combinatorial discovery and clinical translation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkac382

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. Meyer, 2022, Decision rules for identifying combination therapies in open-entry, randomized controlled platform trials, Pharm. Stat., 21, 671, 10.1002/pst.2194 · doi:10.1002/pst.2194
  2. Berenbaum, 1989, What is synergy?, Pharmacol. Rev., 41, 93

Cited by

See all 778

Metadata

Authors
Ianevski, A., Giri, A. K., & Aittokallio, T.
Venue
Nucleic Acids Research
Published
2022-05-17
Volume
50
Issue
W1
Pages
W739-W743
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W4225910596
Cited by
778
References
31
FWCI
69.94
Type
journal article
Language
en
Open access
gold
Funders
  • Academy of Finland (326238, 340141, 345803, 344698)
  • European Union's Horizon 2020 (ERA PerMed JAKSTAT-TARGET)
  • Cancer Society of Finland
  • Sigrid Jusélius Foundation
  • Maud Kuistila Memorial Foundation
  • K. Albin Johanssons stiftelse sr Foundation
  • Norwegian Cancer Society (216104)
  • Fuugin foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. https://app.cochat.ai/papers/10.1093/nar/gkac382
The paper
Ianevski, A., Giri, A. K., & Aittokallio, T. (2022). SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Research. https://doi.org/10.1093/nar/gkac382

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.